CA2253238C - Novel agouti-related gene - Google Patents
Novel agouti-related gene Download PDFInfo
- Publication number
- CA2253238C CA2253238C CA002253238A CA2253238A CA2253238C CA 2253238 C CA2253238 C CA 2253238C CA 002253238 A CA002253238 A CA 002253238A CA 2253238 A CA2253238 A CA 2253238A CA 2253238 C CA2253238 C CA 2253238C
- Authority
- CA
- Canada
- Prior art keywords
- art
- polypeptide
- seq
- nucleic acid
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1750596P | 1996-05-10 | 1996-05-10 | |
| US60/017,505 | 1996-05-10 | ||
| US08/757,541 | 1996-11-27 | ||
| US08/757,541 US5766877A (en) | 1996-05-10 | 1996-11-27 | Genes encoding art, an agouti-related transcript |
| PCT/US1997/006853 WO1997043412A1 (en) | 1996-05-10 | 1997-04-22 | Novel agouti-related gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2253238A1 CA2253238A1 (en) | 1997-11-20 |
| CA2253238C true CA2253238C (en) | 2008-08-12 |
Family
ID=26689965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002253238A Expired - Fee Related CA2253238C (en) | 1996-05-10 | 1997-04-22 | Novel agouti-related gene |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US5766877A (enExample) |
| EP (1) | EP0917571B1 (enExample) |
| JP (1) | JP4219404B2 (enExample) |
| AT (1) | ATE283917T1 (enExample) |
| AU (1) | AU2681497A (enExample) |
| CA (1) | CA2253238C (enExample) |
| DE (1) | DE69731834T2 (enExample) |
| DK (1) | DK0917571T3 (enExample) |
| ES (1) | ES2234015T3 (enExample) |
| PT (1) | PT917571E (enExample) |
| SI (1) | SI0917571T1 (enExample) |
| WO (1) | WO1997043412A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843652A (en) * | 1993-05-21 | 1998-12-01 | Lockheed Martin Energy Systems, Inc. | Isolation and characterization of Agouti: a diabetes/obesity related gene |
| US6310034B1 (en) | 1993-05-21 | 2001-10-30 | Ut-Battelle, Llc | Agouti polypeptide compositions |
| WO2002064091A2 (en) * | 2001-02-13 | 2002-08-22 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
| US5766877A (en) * | 1996-05-10 | 1998-06-16 | Amgen Inc. | Genes encoding art, an agouti-related transcript |
| EP0942967A1 (en) * | 1996-11-06 | 1999-09-22 | Children's Medical Center Corporation | Transgenic animal expressing a syndecan in the regions of hypothalamus |
| US6878520B1 (en) * | 1997-12-16 | 2005-04-12 | Merck & Co., Inc. | C-terminal region of agouti-related transcript (ART) protein |
| DE69838104T2 (de) * | 1997-12-16 | 2008-04-10 | Merck & Co., Inc. | C-terminale region des "agouti-related-transcript"-proteins (art) |
| AU3964499A (en) * | 1998-03-30 | 1999-10-18 | Gryphon Sciences | Agouti-related protein analogs and methods of use |
| US6689873B1 (en) | 1998-04-29 | 2004-02-10 | Merck & Co., Inc. | Nucleic acid encoding rat agouti related protein |
| JP2002524724A (ja) * | 1998-09-03 | 2002-08-06 | ミレニアム ファーマシューティカルズ インク. | 薬物中毒を治療するために用いられる化合物を同定する際の標的としてのmc4−r |
| US6716810B1 (en) * | 1998-12-09 | 2004-04-06 | Eleanor Roosevelt Institute | Composition and method for regulation of body weight and associated conditions |
| US6603058B1 (en) | 1998-12-09 | 2003-08-05 | Oklahoma Medical Research Foundation | Non-human animal model for obesity and uses thereof |
| US6303749B1 (en) * | 1999-01-29 | 2001-10-16 | Amgen Inc. | Agouti and agouti-related peptide analogs |
| US20030064921A1 (en) * | 1999-10-27 | 2003-04-03 | The Regents Of The University Of California | Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| EP1125579A3 (en) | 2000-01-18 | 2003-01-02 | Pfizer Products Inc. | Uses of agrp-melanocortin receptor binding modulating compounds |
| CN100369940C (zh) * | 2000-05-31 | 2008-02-20 | 纳幕尔杜邦公司 | 烯烃聚合催化剂 |
| PT1385823E (pt) | 2001-04-09 | 2007-01-31 | Novartis Vaccines & Diagnostic | Compostos de guanidino como agonistas do receptor de melanocortina-4 (r-mc4) |
| US20050124652A1 (en) * | 2002-02-04 | 2005-06-09 | Rustum Boyce | Guanidino compounds |
| US20030207814A1 (en) * | 2002-02-04 | 2003-11-06 | Chiron Corporation | Novel guanidinyl derivatives |
| US20030195187A1 (en) * | 2002-02-04 | 2003-10-16 | Chiron Corporation | Guanidino compounds |
| US20030229025A1 (en) * | 2002-02-25 | 2003-12-11 | Chiron Corporation | Intranasal administration of MC4-R agonists |
| DE60333937D1 (de) | 2002-05-23 | 2010-10-07 | Novartis Vaccines & Diagnostic | Substituierte quinazolinone verbindungen |
| WO2004004447A2 (en) * | 2002-07-03 | 2004-01-15 | Merck & Co., Inc. | Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| AU2004249120B2 (en) * | 2003-05-23 | 2008-07-24 | Glaxosmithkline | Guanidino-substituted quinazolinone compounds as MC4-R agonists |
| EP1656455B1 (en) * | 2003-08-13 | 2012-09-19 | Sandoz Ag | Process for the purification of recombinant polypeptides |
| AU2004293012A1 (en) * | 2003-11-19 | 2005-06-09 | Rustum S. Boyce | Quinazolinone compounds with reduced bioaccumulation |
| US6974187B2 (en) * | 2004-01-28 | 2005-12-13 | Tachi-S Co., Ltd. | Vehicle seat structure |
| NZ550114A (en) * | 2004-04-20 | 2011-02-25 | Transtech Pharma Inc | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| US7910101B2 (en) | 2004-10-25 | 2011-03-22 | Centocor, Inc. | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| US20070021433A1 (en) | 2005-06-03 | 2007-01-25 | Jian-Qiang Fan | Pharmacological chaperones for treating obesity |
| US7833927B2 (en) * | 2005-08-31 | 2010-11-16 | Rohm And Haas Company | Single site palladium catalyst complexes |
| JP2012501334A (ja) * | 2008-08-29 | 2012-01-19 | トランス テック ファーマ,インコーポレイテッド | 置換アミノチアゾール誘導体、医薬組成物、および使用の方法 |
| WO2012100342A1 (en) | 2011-01-27 | 2012-08-02 | Université de Montréal | Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4263428A (en) * | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| ATE12348T1 (de) * | 1980-11-10 | 1985-04-15 | Gersonde Klaus Prof Dr | Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens. |
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| EP0088046B1 (de) * | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| EP0143949B1 (en) * | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Pharmaceutical composition containing urokinase |
| DE3572982D1 (en) * | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
| JP2989002B2 (ja) * | 1988-12-22 | 1999-12-13 | キリン―アムジエン・インコーポレーテツド | 化学修飾顆粒球コロニー刺激因子 |
| US5252714A (en) * | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| US5766877A (en) * | 1996-05-10 | 1998-06-16 | Amgen Inc. | Genes encoding art, an agouti-related transcript |
-
1996
- 1996-11-27 US US08/757,541 patent/US5766877A/en not_active Expired - Lifetime
-
1997
- 1997-04-22 JP JP54088297A patent/JP4219404B2/ja not_active Expired - Fee Related
- 1997-04-22 DE DE69731834T patent/DE69731834T2/de not_active Expired - Fee Related
- 1997-04-22 PT PT97918802T patent/PT917571E/pt unknown
- 1997-04-22 ES ES97918802T patent/ES2234015T3/es not_active Expired - Lifetime
- 1997-04-22 WO PCT/US1997/006853 patent/WO1997043412A1/en not_active Ceased
- 1997-04-22 AU AU26814/97A patent/AU2681497A/en not_active Abandoned
- 1997-04-22 EP EP97918802A patent/EP0917571B1/en not_active Expired - Lifetime
- 1997-04-22 CA CA002253238A patent/CA2253238C/en not_active Expired - Fee Related
- 1997-04-22 SI SI9730696T patent/SI0917571T1/xx unknown
- 1997-04-22 AT AT97918802T patent/ATE283917T1/de not_active IP Right Cessation
- 1997-04-22 DK DK97918802T patent/DK0917571T3/da active
-
1998
- 1998-03-02 US US09/033,275 patent/US6060589A/en not_active Expired - Fee Related
-
1999
- 1999-06-29 US US09/342,581 patent/US6203995B1/en not_active Expired - Fee Related
-
2001
- 2001-01-05 US US09/754,862 patent/US20010007752A1/en not_active Abandoned
-
2002
- 2002-09-27 US US10/256,590 patent/US7122520B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4219404B2 (ja) | 2009-02-04 |
| AU2681497A (en) | 1997-12-05 |
| ES2234015T3 (es) | 2005-06-16 |
| US20030082737A1 (en) | 2003-05-01 |
| JP2001517931A (ja) | 2001-10-09 |
| DE69731834T2 (de) | 2005-12-15 |
| US6060589A (en) | 2000-05-09 |
| WO1997043412A1 (en) | 1997-11-20 |
| PT917571E (pt) | 2005-04-29 |
| EP0917571A1 (en) | 1999-05-26 |
| US20010007752A1 (en) | 2001-07-12 |
| US5766877A (en) | 1998-06-16 |
| US6203995B1 (en) | 2001-03-20 |
| SI0917571T1 (en) | 2005-06-30 |
| DK0917571T3 (da) | 2005-03-14 |
| CA2253238A1 (en) | 1997-11-20 |
| DE69731834D1 (de) | 2005-01-05 |
| ATE283917T1 (de) | 2004-12-15 |
| US7122520B2 (en) | 2006-10-17 |
| EP0917571B1 (en) | 2004-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2253238C (en) | Novel agouti-related gene | |
| EP1417227B1 (en) | Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
| JP4793836B2 (ja) | 線維芽細胞増殖因子様ポリペプチド | |
| US5741772A (en) | Neurotrophic factor NNT-1 | |
| CA2323525C (en) | Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis | |
| JP3492999B2 (ja) | 脂肪細胞特異的タンパク質の同族体 | |
| KR100334739B1 (ko) | 절단된신경교세포주-유래신경영양성인자단백질산물 | |
| EP1390403B1 (en) | Peptides derived from neural thread proteins and their medical use | |
| MXPA02009224A (es) | Moleculas similares a receptor de factor de crecimiento de fibroblastos y usos de las mismas. | |
| AU4870599A (en) | Delta-related polypeptides | |
| KR20000010571A (ko) | 신경교세포주-유래신경영양성인자수용체및이를코드하는핵산서열과아미노산서열_ | |
| KR20000029912A (ko) | 뉴리틴,신경유전자 | |
| EP0546074A1 (en) | Genetic material encoding igfbp-5 | |
| CA2279999C (en) | The neurotrophic factor nnt-1 | |
| CA2323506C (en) | Mammalian blood loss-induced gene, kd312 | |
| KR100399377B1 (ko) | Gdnf 단백질의 분석방법 및 검정 기구 | |
| MXPA01000980A (en) | Delta-related polypeptides | |
| MXPA00009172A (en) | Mammalian blood loss-induced gene, kd312 | |
| MXPA99001282A (en) | Neuritin, a neurogene | |
| HK1025125B (en) | The neurotrophic factor nnt-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |